AI assistant
Sending…
Perspective Therapeutics, Inc. — Director's Dealing 2017
Jan 6, 2017
33510_dirs_2017-01-06_99f942ed-a029-4385-b744-f5b5136d4233.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IsoRay, Inc. (ISR)
CIK: 0000728387
Period of Report: 2017-01-04
Reporting Person: Vitale Philip J (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-01-04 | Common Stock | P | 17200 | $0.66 | Acquired | 37200 | Direct |
| 2017-01-04 | Common Stock | P | 100 | $0.6575 | Acquired | 37300 | Direct |
| 2017-01-04 | Common Stock | P | 2700 | $0.655 | Acquired | 40000 | Direct |
More from Perspective Therapeutics, Inc.
Regulatory Filings
2026
May 27
Regulatory Filings
2026
May 21
Major Shareholding Notification
2026
May 12
Interim / Quarterly Report
2026
May 11
Regulatory Filings
2026
May 11
Regulatory Filings
2026
May 4
Major Shareholding Notification
2026
Apr 27
Regulatory Filings
2026
Apr 20
Proxy Solicitation & Information Statement
2026
Apr 16
Proxy Solicitation & Information Statement
2026
Apr 16